Q FEVER, DIAGNOSIS AND MANAGEMENT
In the other treatment-experienced trial (VIKING-3), one subject experienced SAEs considered related to dolutegravir which was a case of drug eruption with elevated ALT and hyperbilirubinemia. In the 60-day Safety Update Report, one subject had a suicide attempt that was taking dolutegravir for approximately one year at the time of the attempt. ................
................
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related searches
- strategic planning and management pdf
- myocardial infarction diagnosis and treatment
- business principles and management textbook
- employee factors and management factors
- work and management philosophy
- financial accounting and management accounting
- maintenance reporting and management system
- financial management and management accounting
- cost and management accounting questions
- leadership and management scholarly articles
- business administration and management journal
- diagnosis and differential diagnosis